HMGB1 and Huntington disease: In clinical practice, our results might suggest stratifying HD patients according to FLCs and HMGB1 levels, personalizing the dialytic prescription with potential benefits from diffusive–convective methods and HDx techniques, and identifying patients with high mortality risk.